Vascular Imaging Devices Market By Type (Minimally Invasive [Catheter Angiogram, CT Angiography [CTA], Lymphoscintigraphy, Venogram, Intravascular Ultrasound], Non-Invasive [Abdominal Ultrasound, Angiography, Ankle-Brachial Index [ABI], Captopril Renal Scan, Magnetic Resonance Angiography [MRA], Magnetic Resonance Imaging [MRI], Carotid Duplex Ultrasound, CT Scan, Doppler Ultrasound, Duplex Ultrasound), By Application (Diagnostics and Therapeutics), By End-User (Hospitals, Diagnostic Imaging Centers, Others), By Geography is expected to grow at a steady CAGR Forecast till 2026 owing to rising technological advancement and increasing prevalence of Vascular-Related Diseases
Global Vascular Imaging Devices Market was valued at USD 7.73 billion in 2020, growing at a CAGR of 5.51% during the forecast period from 2021 to 2026, to reach USD 10.61 billion by 2026. The demand for Vascular Imaging Devices is primarily motivated by the prevalence of a vast number of patients suffering from vascular-related diseases like hypertension, arrhythmias, and diabetes, additionally, vascular imaging devices were found to be extremely beneficial in COVID-19 cases in the pandemic situation which further pushed for the demand of these devices. Moreover, technological advancements and requirements of these devices for proper surgical planning and long-term disease management will eventually boost the market growth. The fact that Vascular Imaging is usually a non-invasive procedure is also escalating the growth of the market.
Vascular Imaging Devices are used in diagnosing vascular-related diseases by viewing vascular tissues. The increasing prevalence of diabetes and hypertension are responsible to drive the growth of the Vascular Imaging Devices market. Also, due to the technological advancements the devices are non-invasive and are used by several radiologists to identify vascular anatomy.
Based on data from NHANES (National Health and Nutrition Examination Survey; 2013–2016), an estimated 26 million adults have been diagnosed with diabetes, 9.4 million adults (3.7%) have undiagnosed diabetes, and 91.8 million adults (37.6%) have prediabetes.
As per American Heart Association, 2021, the incidence of end-stage kidney disease in the United States is projected to increase 11% to 18% through 2030. This will eventually lead to more prevalence of renal diseases and it will further boost the Global Vascular Imaging Devices market growth.
With the outbreak of COVID-19, almost all the countries were affected. Currently, numerous countries have started to improve their healthcare systems. Hence, as a preventive measure, governments across the world have started building new hospitals and diagnostic centers, where vascular imaging is kept as utmost priority. Henceforth, it requires vascular imaging devices, such as Ultrasound and CT, MRI machines.
Screening at home is critical in stopping the virulent spread of the virus. According to a paper published by the Chinese Center for Disease Control and Prevention, in February 2020, only 19% of patients who contracted COVID-19 had conditions severe enough to require hospitalization. The effect on the other 81% was mild enough for them to recover safely at home. This 19% will require the use of ultrasound imaging of both their lungs, which will substantially promote the market for vascular imaging devices. Thus, all these factors are projected to drive the growth of the market for Vascular Imaging Devices.
Certain factors such as the very high cost of the equipment and the requirement of skilled and trained professionals for operating pose a major hurdle for the growth of the Vascular Imaging Devices market
Vascular Imaging Devices by Type (Minimally Invasive [Catheter Angiogram, CT Angiography [CTA], Lymphoscintigraphy, Venogram, Intravascular Ultrasound], Non-Invasive [Abdominal Ultrasound, Angiography, Ankle-Brachial Index [ABI], Captopril Renal Scan, Magnetic Resonance Angiography [MRA], Magnetic Resonance Imaging [MRI], Carotid Duplex Ultrasound, CT Scan, Doppler Ultrasound, Duplex Ultrasound), Vascular Imaging Devices market by Application (Diagnostics And Therapeutics), Vascular Imaging Devices market by End User (Hospitals, Diagnostic Imaging Centers, Others), and Vascular Imaging Devices market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
Vascular Imaging Devices market type segment, non-invasive devices are expected to hold the largest share in the market as it is an important tool in the clinical assessment of patients, with a variety of vascular-related conditions. It allows the detection of changes in blood flow and rhythm, and it is essential in the detection of life-threatening arrhythmias. There are various types of non-invasive devices available in the Vascular Imaging Devices market, such as Abdominal Ultrasound, Angiography, Captopril Renal Scan, MRA, MRI, Carotid Duplex Ultrasound, CT Scan, Doppler Ultrasound, Duplex Ultrasound, among others.
The Vascular Imaging Devices market is driven by the factors such as the increase in the prevalence of heart disease, like stroke, and a growing aging population who are very susceptible to coronary heart disease, technological developments in vascular imaging devices that minimize the chances of further infection, and improved efficiency of devices. In August 2021, The US Food and Drug Administration (FDA) has cleared Abbott's latest optical coherence tomography (OCT) imaging platform powered by the company's new Ultreon Software. It combines OCT with artificial intelligence (AI) to provide physicians an enhanced, comprehensive view of coronary blood flow and blockages to assist physician decision-making in the cath lab and provide the best pathway for treatment.
Additionally, assistance from government bodies, in equipping new/existing hospitals and healthcare centers in rural regions, is expected to enhance the market potential in several countries. Hence, all the above-mentioned factors are expected to drive the segment growth.
North America is expected to dominate the overall Vascular Imaging Devices market during the forecast period. This domination is due to the growing demand for advanced technologies in these devices, the increasing vascular diseases in the region are driving the regional growth. Additionally, high capital expenditure like building super-specialty Hospitals and Surgical centers is expected to boost the Global Vascular Imaging Devices market growth.
Further, In the United States, according to the Centers for Disease Control and Prevention (CDC), in 2020, approximately 6.5 million people age 40 and older have PAD, which in turn, will increase the demand for Vascular Imaging devices. This situation is giving rise to a critical need for Vascular Imaging devices for the diagnosis, prevention, and treatment of the disease.
Europe and Asia-Pacific region have the future potential growth for the Global Vascular Imaging Devices. This is due to the fact that many key players are now available in these regions. In all countries, vascular-related illness rates have been increasing. Several reports have been released annually, mentioning that significant portions of the population in the European Union and the United States (including in the developed market) suffer through more than one chronic disorder, such as hypertension, arrhythmias, diabetes, for a prolonged period, thus there is an enormous potential for Vascular Imaging Devices market growth.
Some of the key market players operating in the Vascular Imaging Devices market include Siemens Healthineers, GE Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Samsung Medison, Shimadzu Corporation, St. Jude Medical, Inc., TERUMO Corporation, Koninklijke Philips N.V., Hologic, Inc., Esaote SpA, Carestream Health, Inc. and others.
What are Vascular Imaging Devices?
Vascular imaging devices are used in diagnosing vascular-related diseases by viewing vascular tissues. The increasing prevalence of diabetes and hypertension are responsible to drive the growth of the market. Also, due to the technological advancements the devices are non-invasive and are used by several radiologists to identify vascular anatomy.
What is the market for Global Vascular Imaging Devices?
Global Vascular Imaging Devices Market was valued at USD 7.73 billion in 2020, growing at a CAGR of 5.51% during the forecast period from 2021 to 2026, to reach USD 10.61 billion by 2026.
What are the drivers for Global Vascular Imaging Devices?
The major drivers driving the demand for Vascular Imaging Devices are the prevalence of a vast number of patients suffering from vascular-related diseases like hypertension, arrhythmias, and diabetes, additionally, vascular imaging devices were found to be extremely beneficial in COVID-19 cases in the pandemic situation.
What are the key players operating in Global Vascular Imaging Devices?
Some of the key market players operating in the Vascular Imaging Devices market include Siemens Healthineers, GE Healthcare, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Samsung Medison, Shimadzu Corporation, St. Jude Medical, Inc., TERUMO Corporation, Koninklijke Philips N.V., Hologic, Inc., Esaote SpA, Carestream Health, Inc. and others.
What regions have the highest share in the Vascular Imaging Devices market?
North America is expected to dominate the overall Vascular Imaging Devices market during the forecast period, 2021 to 2026. This domination is due to the growing demand for advanced technologies in these devices, the increasing vascular diseases in the region are driving the regional growth. Additionally, high capital expenditure like building super-specialty Hospitals and Surgical centers is expected to boost the market growth.
1. Vascular Imaging Devices Market Report Introduction
2. Vascular Imaging Devices Market Executive summary
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial Benchmarking
3. Regulatory and Patent Analysis
3.1. The United States
3.2. Europe
3.2.1. Germany
3.2.2. France
3.2.3. Italy
3.2.4. Spain
3.2.5. U.K.
3.3. Japan
4. Vascular Imaging Devices Market Key factors analysis
4.1. Vascular Imaging Devices Market Drivers
4.1.1. Growing prevalence of vascular-related diseases in the rising geriatric population
4.1.2. Outbreak of the Covid-19 pandemic
4.1.3. Technological advancements in product development
4.1.4. Increasing adoption rates of minimally invasive surgeries
4.2. Vascular Imaging Devices Market Restraints and Challenges
4.2.1. High cost of equipment
4.2.2. Unavailability of skilled and trained professionals
4.3. Vascular Imaging Devices Market Opportunities
4.3.1. Increasing health awareness in emerging countries
4.3.2. Growing demand for vascular imaging devices in multispeciality and diagnostic care settings
5. Vascular Imaging Devices Porter’s Five Forces Analysis
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry
6. COVID-19 Impact Analysis on Vascular Imaging Devices Market
7. Vascular Imaging Devices Market layout
7.1. By Type
7.1.1. Minimally Invasive
7.1.1.1. Catheter Angiogram
7.1.1.2. CT Angiography (CTA)
7.1.1.3. Lymphoscintigraphy
7.1.1.4. Venogram
7.1.1.5. Intravascular Ultrasound
7.1.2. Non-Invasive
7.1.2.1. Abdominal Ultrasound
7.1.2.2. Angiography
7.1.2.3. Ankle-Brachial Index (ABI)
7.1.2.4. Captopril Renal Scan
7.1.2.5. Carotid Duplex Ultrasound
7.1.2.6. CT Scan
7.1.2.7. Doppler Ultrasound
7.1.2.8. Duplex Ultrasound
7.1.2.9. Magnetic Resonance Angiography (MRA)
7.1.2.10. Magnetic Resonance Imaging (MRI)
7.2. By Application
7.2.1. Diagnostics
7.2.2. Therapeutics
7.3. By End-user
7.3.1. Hospitals
7.3.2. Diagnostic Imaging Centers
7.3.3. Others
7.4. By Geography
7.4.1. North America
7.4.1.1. North America Interventional Cardiology Devices Market, by Type
7.4.1.2. North America Interventional Cardiology Devices Market, by Application
7.4.1.3. North America Interventional Cardiology Devices Market, by End-user
7.4.1.4. North America Interventional Cardiology Devices Market, by Country
7.4.1.4.1. United States
7.4.1.4.2. Canada
7.4.1.4.3. Mexico
7.4.2. Europe
7.4.2.1. Europe Interventional Cardiology Devices Market, by Type
7.4.2.2. Europe Interventional Cardiology Devices Market, by Application
7.4.2.3. Europe Interventional Cardiology Devices Market, by End-user
7.4.2.4. Europe Interventional Cardiology Devices Market, by Country
7.4.2.4.1. France
7.4.2.4.2. Germany
7.4.2.4.3. United Kingdom
7.4.2.4.4. Italy
7.4.2.4.5. Spain
7.4.2.4.6. Russia
7.4.2.4.7. Rest of Europe
7.4.3. Asia-Pacific
7.4.3.1. Asia-Pacific Interventional Cardiology Devices Market, by Type
7.4.3.2. Asia-Pacific Interventional Cardiology Devices Market, by Application
7.4.3.3. Asia-Pacific Interventional Cardiology Devices Market, by End-user
7.4.3.4. Asia-Pacific Interventional Cardiology Devices Market, by Country
7.4.3.4.1. China
7.4.3.4.2. Japan
7.4.3.4.3. India
7.4.3.4.4. Australia
7.4.3.4.5. South Korea
7.4.3.4.6. Rest of Asia Pacific
7.4.4. Rest of the World (RoW)
7.4.4.1. RoW Interventional Cardiology Devices Market, by Type
7.4.4.2. RoW Interventional Cardiology Devices Market, by Application
7.4.4.3. RoW Interventional Cardiology Devices Market, by End-user
7.4.4.4. RoW Interventional Cardiology Devices Market, by Region
7.4.4.4.1. Middle East
7.4.4.4.2. Africa
7.4.4.4.3. South America
8. Vascular Imaging Devices Global Company Share Analysis – Key 3-5 Companies
9. Vascular Imaging Devices Company and Product Profiles
9.1. Siemens Healthcare Limited
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Financial Overview
9.1.4. Product Listing
9.1.5. Entropy
9.2. General Electric Company (GE Healthcare)
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Financial Overview
9.2.4. Product Listing
9.2.5. Entropy
9.3. Koninklijke Philips N.V.
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Financial Overview
9.3.4. Product Listing
9.3.5. Entropy
9.4. FUJIFILM Healthcare
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Financial Overview
9.4.4. Product Listing
9.4.5. Entropy
9.5. Samsung Medison Co., Ltd.
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Financial Overview
9.5.4. Product Listing
9.5.5. Entropy
9.6. Shimadzu Corporation
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Financial Overview
9.6.4. Product Listing
9.6.5. Entropy
9.7. Hologic, Inc.
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Financial Overview
9.7.4. Product Listing
9.7.5. Entropy
9.8. Abbott Laboratories
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Financial Overview
9.8.4. Product Listing
9.8.5. Entropy
9.9. Carestream Health Inc.
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Financial Overview
9.9.4. Product Listing
9.9.5. Entropy
9.10. Toshiba Medical Systems Corporation
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Financial Overview
9.10.4. Product Listing
9.10.5. Entropy
9.11. Terumo Corporation
9.11.1. Company Overview
9.11.2. Company Snapshot
9.11.3. Financial Overview
9.11.4. Product Listing
9.11.5. Entropy
9.12. ESAOTE SPA
9.12.1. Company Overview
9.12.2. Company Snapshot
9.12.3. Financial Overview
9.12.4. Product Listing
9.12.5. Entropy
9.13. Konica Minolta, Inc.
9.13.1. Company Overview
9.13.2. Company Snapshot
9.13.3. Financial Overview
9.13.4. Product Listing
9.13.5. Entropy
9.14. Alpinion Medical Systems Co., Ltd.
9.14.1. Company Overview
9.14.2. Company Snapshot
9.14.3. Financial Overview
9.14.4. Product Listing
9.14.5. Entropy
9.15. Pie Medical Imaging B.V
9.15.1. Company Overview
9.15.2. Company Snapshot
9.15.3. Financial Overview
9.15.4. Product Listing
9.15.5. Entropy
10. Project Approach
10.1. Secondary Sources
10.2. Primary Sources
10.3. Data Triangulation
10.4. Key Expert Opinions
11. KOL Views
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight
List of Table
Table 1: Competitive Analysis
Table 2: COVID-19 Impact Analysis
Table 3: Vascular Imaging Devices in Global (2018-2026)
Table 4: Vascular Imaging Devices in Global by Type (2018-2026)
Table 5: Vascular Imaging Devices in Global by Application (2018-2026)
Table 6: Vascular Imaging Devices in Global by End User (2018-2026)
Table 7: Vascular Imaging Devices in Global by Geography (2018-2026)
Table 8: Vascular Imaging Devices in North America (2018-2026)
Table 9: Vascular Imaging Devices in North America by Type (2018-2026)
Table 10: Vascular Imaging Devices in North America by Application (2018-2026)
Table 11: Vascular Imaging Devices in North America by End User (2018-2026)
Table 12: Vascular Imaging Devices in North America by Country (2018-2026)
Table 13: Vascular Imaging Devices in the US (2018-2026)
Table 14: Vascular Imaging Devices in Canada (2018-2026)
Table 15: Vascular Imaging Devices in Mexico (2018-2026)
Table 16: Vascular Imaging Devices in Europe (2018-2026)
Table 17: Vascular Imaging Devices in Europe by Type (2018-2026)
Table 18: Vascular Imaging Devices in Europe by Application (2018-2026)
Table 19: Vascular Imaging Devices in Europe by End User (2018-2026)
Table 20: Vascular Imaging Devices in Europe by Country (2018-2026)
Table 21: Vascular Imaging Devices in France (2018-2026)
Table 22: Vascular Imaging Devices in Germany (2018-2026)
Table 23: Vascular Imaging Devices in UK (2018-2026)
Table 24: Vascular Imaging Devices in Italy (2018-2026)
Table 25: Vascular Imaging Devices in Spain (2018-2026)
Table 26: Vascular Imaging Devices in Russia (2018-2026)
Table 27: Vascular Imaging Devices in Rest of Europe (2018-2026)
Table 28: Vascular Imaging Devices in Asia Pacific (2018-2026)
Table 29: Vascular Imaging Devices in Asia Pacific by Type (2018-2026)
Table 30: Vascular Imaging Devices in Asia Pacific by Application (2018-2026)
Table 31: Vascular Imaging Devices in Asia Pacific by End User (2018-2026)
Table 32: Vascular Imaging Devices in Asia Pacific by Country (2018-2026)
Table 33: Vascular Imaging Devices in China (2018-2026)
Table 34: Vascular Imaging Devices in Japan (2018-2026)
Table 35: Vascular Imaging Devices in India (2018-2026)
Table 36: Vascular Imaging Devices in Australia (2018-2026)
Table 37: Vascular Imaging Devices in South Korea (2018-2026)
Table 38: Vascular Imaging Devices in Rest of Asia Pacific (2018-2026)
Table 39: Vascular Imaging Devices in Rest of the World (2018-2026)
Table 40: Vascular Imaging Devices in Rest of the World by Type (2018-2026)
Table 41: Vascular Imaging Devices in Rest of the World by Application (2018-2026)
Table 42: Vascular Imaging Devices in Rest of the World by End User (2018-2026)
Table 43: Vascular Imaging Devices in Rest of the World by Country (2018-2026)
Table 44: Vascular Imaging Devices in Middle East (2018-2026)
Table 45: Vascular Imaging Devices in Africa (2018-2026)
Table 46: Vascular Imaging Devices in South America (2018-2026)
List of Figures
Figure 1: Competitive Analysis
Figure 2: COVID-19 Impact Analysis
Figure 3: Vascular Imaging Devices in Global (2018-2026)
Figure 4: Vascular Imaging Devices in Global by Type (2018-2026)
Figure 5: Vascular Imaging Devices in Global by Application (2018-2026)
Figure 6: Vascular Imaging Devices in Global by End User (2018-2026)
Figure 7: Vascular Imaging Devices in Global by Geography (2018-2026)
Figure 8: Vascular Imaging Devices in North America (2018-2026)
Figure 9: Vascular Imaging Devices in North America by Type (2018-2026)
Figure 10: Vascular Imaging Devices in North America by Application (2018-2026)
Figure 11: Vascular Imaging Devices in North America by End User (2018-2026)
Figure 12: Vascular Imaging Devices in North America by Country (2018-2026)
Figure 13: Vascular Imaging Devices in the US (2018-2026)
Figure 14: Vascular Imaging Devices in Canada (2018-2026)
Figure 15: Vascular Imaging Devices in Mexico (2018-2026)
Figure 16: Vascular Imaging Devices in Europe (2018-2026)
Figure 17: Vascular Imaging Devices in Europe by Type (2018-2026)
Figure 18: Vascular Imaging Devices in Europe by Application (2018-2026)
Figure 19: Vascular Imaging Devices in Europe by End User (2018-2026)
Figure 20: Vascular Imaging Devices in Europe by Country (2018-2026)
Figure 21: Vascular Imaging Devices in France (2018-2026)
Figure 22: Vascular Imaging Devices in Germany (2018-2026)
Figure 23: Vascular Imaging Devices in UK (2018-2026)
Figure 24: Vascular Imaging Devices in Italy (2018-2026)
Figure 25: Vascular Imaging Devices in Spain (2018-2026)
Figure 26: Vascular Imaging Devices in Russia (2018-2026)
Figure 27: Vascular Imaging Devices in Rest of Europe (2018-2026)
Figure 28: Vascular Imaging Devices in Asia Pacific (2018-2026)
Figure 29: Vascular Imaging Devices in Asia Pacific by Type (2018-2026)
Figure 30: Vascular Imaging Devices in Asia Pacific by Application (2018-2026)
Figure 31: Vascular Imaging Devices in Asia Pacific by End User (2018-2026)
Figure 32: Vascular Imaging Devices in Asia Pacific by Country (2018-2026)
Figure 33: Vascular Imaging Devices in China (2018-2026)
Figure 34: Vascular Imaging Devices in Japan (2018-2026)
Figure 35: Vascular Imaging Devices in India (2018-2026)
Figure 36: Vascular Imaging Devices in Australia (2018-2026)
Figure 37: Vascular Imaging Devices in South Korea (2018-2026)
Figure 38: Vascular Imaging Devices in Rest of Asia Pacific (2018-2026)
Figure 39: Vascular Imaging Devices in Rest of the World (2018-2026)
Figure 40: Vascular Imaging Devices in Rest of the World by Type (2018-2026)
Figure 41: Vascular Imaging Devices in Rest of the World by Application (2018-2026)
Figure 42: Vascular Imaging Devices in Rest of the World by End User (2018-2026)
Figure 43: Vascular Imaging Devices in Rest of the World by Country (2018-2026)
Figure 44: Vascular Imaging Devices in Middle East (2018-2026)
Figure 45: Vascular Imaging Devices in Africa (2018-2026)
Figure 46: Vascular Imaging Devices in South America (2018-2026)
Figure 47: Market Drivers
Figure 48: Market Barriers
Figure 49: Market Opportunities
Figure 50: PORTER'S Five Force Analysis
Siemens Healthineers
GE Healthcare
Toshiba Medical Systems Corporation
Hitachi Medical Corporation
Samsung Medison
Shimadzu Corporation
St. Jude Medical, Inc.
TERUMO Corporation
Koninklijke Philips N.V.
Hologic, Inc
Esaote SpA
Carestream Health, Inc. and others.
